BIOMAT Database Logo BIOMAT Database Logo

GLC determination for ftorafur in biological fluids. 1977

E B Hills, and V C Godefroi, and I A O'Leary, and M Burke, and D Andrzejewski, and W Brukwinski, and J P Horwitz

A GLC analysis for free ftorafur was developed to follow in drug disposition in body fluids of patients. The free drug was extracted from aqueous biological samples with chloroform, derivatized by methylation, and chromatographed on 1% HI-EFF 8BP using flame-ionization detection. The analysis is sensitive (0.25 microgram/ml of plasma) and specific for the intact molecule, and it does not interfere with subsequent fluorouracil analysis of the same sample.

UI MeSH Term Description Entries
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D005641 Tegafur Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms. 1-(2-Tetrahydrofuryl)-5-fluorouracil,1-(Tetrahydro-2-furanyl)-5-fluorouracil,5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione,FT-207,FT207,Florafur,Fluorofur,Ftorafur,Futraful,N1-(2'-Tetrahydrofuryl)-5-fluorouracil,Sunfural S,Uftoral,Utefos,FT 207
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E B Hills, and V C Godefroi, and I A O'Leary, and M Burke, and D Andrzejewski, and W Brukwinski, and J P Horwitz
GLC determination of bretylium in biological fluids.
June 1980, Journal of pharmaceutical sciences,
E B Hills, and V C Godefroi, and I A O'Leary, and M Burke, and D Andrzejewski, and W Brukwinski, and J P Horwitz
GLC determination of pentylenetetrazol in biological fluids.
October 1972, Journal of pharmaceutical sciences,
E B Hills, and V C Godefroi, and I A O'Leary, and M Burke, and D Andrzejewski, and W Brukwinski, and J P Horwitz
GLC determination of probenecid in biological fluids.
December 1973, Journal of pharmaceutical sciences,
E B Hills, and V C Godefroi, and I A O'Leary, and M Burke, and D Andrzejewski, and W Brukwinski, and J P Horwitz
GLC determination of theophylline in biological fluids.
August 1974, Journal of pharmaceutical sciences,
E B Hills, and V C Godefroi, and I A O'Leary, and M Burke, and D Andrzejewski, and W Brukwinski, and J P Horwitz
GLC determination of procainamide in biological fluids.
December 1975, Journal of pharmaceutical sciences,
E B Hills, and V C Godefroi, and I A O'Leary, and M Burke, and D Andrzejewski, and W Brukwinski, and J P Horwitz
GLC determination of pemoline in biological fluids.
March 1978, Journal of pharmaceutical sciences,
E B Hills, and V C Godefroi, and I A O'Leary, and M Burke, and D Andrzejewski, and W Brukwinski, and J P Horwitz
GLC determination of papaverine in biological fluids.
October 1974, Journal of pharmaceutical sciences,
E B Hills, and V C Godefroi, and I A O'Leary, and M Burke, and D Andrzejewski, and W Brukwinski, and J P Horwitz
GLC determination of itanoxone in biological fluids.
August 1981, Journal of pharmaceutical sciences,
E B Hills, and V C Godefroi, and I A O'Leary, and M Burke, and D Andrzejewski, and W Brukwinski, and J P Horwitz
Quantitative GLC determination of pentylenetetrazol in biological fluids.
November 1975, Journal of pharmaceutical sciences,
E B Hills, and V C Godefroi, and I A O'Leary, and M Burke, and D Andrzejewski, and W Brukwinski, and J P Horwitz
Determination of tranquillizers by GLC in biological fluids.
September 1971, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!